Drug Profile
Anti-tissue factor/factor VIIA sheep monoclonal antibody
Latest Information Update: 14 May 2001
Price :
$50
*
At a glance
- Originator KS Biomedix Holdings; Nonindustrial source
- Class Monoclonal antibodies
- Mechanism of Action Factor VIIa inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Solid tumours
Most Recent Events
- 14 May 2001 Discontinued-Preclinical for Solid tumours in United Kingdom (Unknown route)
- 17 Oct 2000 This product is available for licensing (http://www.ksbiomedix.com)
- 16 Dec 1997 Preclinical development for Solid tumours in United Kingdom (Unknown route)